Jeffrey T. L. Smith, Managing Director at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 5,040 shares at $15.26 ($78K) on 2018-10-01, disclosed to the SEC on 2018-10-03.
Scheduled sale ($78k) by Managing Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.26 | 3,040 | $46K | 59.2% |
| 2 | $15.97 | 2,000 | $32K | 40.8% |
| Total | $15.54 avg | 5,040 | $78K | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $332K | — | Filing → |
| ALDR | SELL | 2019-09-18 | $1.2M | — | Filing → |
| ALDR | SELL | 2018-12-04 | $140K | — | Filing → |